TO THE EDITOR: I found Delitto and colleagues' article (1) at odds with not only my experience but that of other published studies. The way that the data and results were reported leaves more questions than answers.
TO THE EDITOR:
We congratulate Delitto and colleagues (1) for conducting a randomized, controlled trial comparing surgery with PT for the treatment of lumbar spinal stenosis (LSS). However, we have serious concerns about their methods, particularly their interpretation of the results. We do not agree that the study shows that "surgical decompression yielded similar effects to a PT regimen among patients with LSS who were surgical candidates." We believe that adherence to intention-to-treat analysis severely distorts the results and leads to erroneous conclusions. Figure 1 indicates that almost two thirds of suitable patients (312 of 481) declined to participate and to be randomly assigned. No information on these patients was presented, but, on the basis of previous, larger, similar studies, these nonparticipants probably experienced greater disability than those who volunteered for randomization (2, 3) . This factor raises doubts about this study's external validity.
Of the patients allocated to PT, 57% crossed over to surgery after receiving an average of 7.8 PT sessions. In the "real world," crossover equates to treatment failure, yet the authors do not seem to acknowledge this when analyzing PT success. As treated, only 15 of 73 PT patients (21%) had a "successful" outcome. Two patients crossed over from surgery to PT, presumably doing so before surgery took place. This circumstance delineates the near impossibility of performing a randomized, controlled trial between surgical and nonsurgical care options and represents temporal inequality.
The value of intention-to-treat analysis in maintaining the benefits of randomization is clear when crossover rates are low and study groups compare equivalent medical treatments. However, this method is inappropriate when comparing surgical versus nonsurgical treatments when crossover is high in 1 study group. Such trials tend to select a cohort of mildly severe cases of the study condition and have prolonged delays in recruitment, as did this one.
In clinical practice, many patients have had unsuccessful experiences with nonsurgical care, including PT, before considering surgery for a degenerative disorder, such as LSS. As Delitto and colleagues' study shows, some will experience satisfactory improvement with PT. However, this study also shows that many persons with substantial disability will opt out of PT and instead choose surgical decompression. Including these patients as PT "successes" is therefore inappropriate. To suggest that this study's findings show equivalence of PT and surgery represents a failure of the study's methods and analysis. Comparing surgical versus nonsurgical therapies with high crossover remains a challenge for methods of evidencebased medicine. TO THE EDITOR: Delitto and colleagues (1) conclude that surgical decompression yielded effects similar to those of a PT regimen among LSS surgical candidates. The authors recommend decision-making conversations between patients and health care providers, as has been previously stated (2) .
Data to guide providers and patients in complex judgments about LSS were not specified and have not been conclusive (2, 3) . Treatment of this condition was described as a balancing act needing an expansive research agenda (2) . Randomized trials show average efficacy of therapy and do not reveal different clinical subgroups within a broad spectrum of disease (4) . Individual distinctions are crucial features of good patient care and concerns for what patients feel, think, or want (4).
Delitto and colleagues state, "The surgical approach in these studies has been highly standardized." However, opinions differ on whether to perform decompression with or without fusion or instrumentation (5) . Of note, a person's medical and physical circumstances and expected quality-of-life outcomes further complicate treatment decisions in LSS. A chronic disease model may preferably be applied to this condition. Elements can include effective communication among professionals, including PT, primary or specialist medical providers, and consulting surgeons; patient-focused education and services; and coordination of cost-effective, timely, and evidence-based interventional managements or procedures. The complexity of LSS merits research on personalized management and outcome studies.
In a private context, one of us was diagnosed with multilevel, bilateral, severe (as shown on magnetic resonance imaging), symptomatic LSS in December 2013, and decision making was difficult. The patient-clinician was knowledgeable in spine biomechanics and clinical epidemiology, and decompressive surgery took place on 10 March 2015. Previous chronic stiffness of the lower extremities, tightness, and guarded gait were promptly relieved, and he resumed his academic office functions 3 weeks after surgery. Home PT is increasing lower-extremity strength and coordination. Even if this favorable personal assessment persists and could be completely objective, as Aristotle stated, "One swallow does not a summer make."
We call for research in personalized assessment and management of patients in the multifaceted LSS spectrum, including validated rating scales for the severity of central stenosis and objective evaluations of patients' physical functioning, neurologic status (such as deficits), overall physical condition, and expected quality of life. Such systematic data gathering and tracking of the course of this chronic and progressive disorder could help attain more timely personalized decisions shared by informed patients and designated providers.
Alfonse T. Masi, MD, DrPH Sam Betts, PT, DPT, MOMT University of Illinois College of Medicine at Peoria and
Midwest Orthopaedic Center Peoria, Illinois IN RESPONSE: We agree with Dr. Barrer that conservative care should precede considering surgery. However, we disagree that not having prior PT is a "breach of . . . care." Exactly what constitutes conservative care is not universally agreed upon. Physical therapy is 1 form, as is watchful waiting, epidural steroids, drug regimens, and many combinations. In our study, surgeons deemed patients surgical candidates largely because conservative care-including, in some cases, previous PT-had been unsuccessful.
As for the high crossover rate, complier average causal effect and inverse probability weighting analyses were done to address that issue. In terms of success rates of surgery, it would be helpful if Dr. Barrer had included references, because definitions of success can vary. We defined it as improvement by an SD of 0.5 regardless of crossover status, because we believed that the risks of surgery warranted setting a high bar.
As for the implication that the surgical group did not fare well overall, the plot of the group means suggests otherwise and strongly parallels the outcomes of the surgical groups in SPORT (Spine Patient Outcomes Research Trial) and Malmivaara and colleagues' trials. The text and Appendix Table 4 of our article list 33 complications (22 in the surgery group and 11 in the PT group) that the table clearly details. Other studies that actually surveyed complications had similar rates (for example, the reoperation rate was 8% in SPORT and 6% in Malmivaara and colleagues' trial) (1, 2) .
In response to Dr. Robertson and associates, we agree that generalizability of study results was limited to patients who agreed to a 50% chance to be randomly assigned to PT. Most patients who declined random assignment cited the strong desire to have surgery as the reason, and it cannot be assumed that these results would generalize to that group. Understanding that internal versus external validity is a balancing act, we sacrificed generalizability to strengthen internal validity by reducing crossover in at least 1 of the study groups.
We disagree that the number of PT sessions is related to treatment failure. The most often-cited reason for discontinuing PT was the burden of copayments. As for the 2 crossovers from surgery to PT, we agree that it is impossible to perfectly compare surgical versus nonsurgical care. However, with such a minuscule crossover rate in the surgical group, we believe that we achieved the goal of reducing crossover in 1 group, allowing for meaningful intention-to-treat analyses. We agree that crossovers in the PT group presented a challenge in analyses, something that we tried to address using complier average causal effect and inverse probability weighting. (1) do not acknowledge the lack of evidence showing that dieting-induced weight loss reduces mortality or cardiovascular events in obese persons. In a large, multicenter intensive diet and lifestyle intervention trial, cardiovascular events (heart disease, stroke, and cardiovascular-related deaths) did not decrease in obese and overweight diabetics despite these participants losing 6% of their body weight with a median follow-up of 9.6 years (2) . Although the large, sustained weight loss associated with bariatric surgery decreases mortality in morbidly obese patients (3), weight loss from dieting has not shown similar benefits (4) . In contrast, improving cardiorespiratory fitness in obese persons reduces the risk for all-cause and cardiovascular disease mortality (5) . Given the unproven benefits and difficulty of maintaining diet-induced weight loss, clinicians are best advised to focus on improving cardiorespiratory fitness and metabolic risk factors in their obese patients. The evidence base justifying the medical management of obesity with improved fitness and exercise is stronger than that for weight loss from dieting and referrals to commercial weightloss programs.
Anthony Delitto, PT, PhD

James T. Langland, MD
University of Minnesota Minneapolis, Minnesota TO THE EDITOR: Gudzune and colleagues' review (1) underscores the need to enhance the modest weight loss that lifestyle or behavioral interventions typically produce. However, the manner in which they convey the designs and results of the included trials, although succinct, could be misinterpreted. First, the authors describe the comparators for the commercial programs as "control/education" (that is, placebo) or "behavioral counseling" (that is, active control). "Behavioral counseling" does not completely describe the comparator interventions, many of which included dietary and physical activity counseling over many visits and some of which differed only in terms of the macronutrient composition (2-4) . Second, the authors summarize the results as mean differences between the commercial programs and their comparators, emphasizing comparative effectiveness instead of overall effectiveness (that is, changes from baseline). For example, they report the results of the Atkins studies as "0.1% to 2.9% greater weight loss at 12 months than counseling," but the weight loss achieved during the study for the Atkins interventions ranged from 3.4% to 12.9%. Thus, reporting additional summary data for an intervention, such as mean weight loss from baseline with a CI, would also be informative. The editorial mentions the possible misinterpretation of results presented in this way by stating that these programs caused "negligible to modest weight loss" (5 IN RESPONSE: Dr. Langland states that modest weight loss achieved through lifestyle change has failed to reduce mortality or cardiovascular events and that referrals to commercial weight-loss programs should therefore be avoided. Although we agree that long-term benefit for cardiovascular events or mortality through modest weight loss has not been proved, clinical guidelines from the American Heart Association, American College of Cardiology, The Obesity Society (1), and the U.S. Preventive Services Task Force (2) currently recommend weight loss for its benefits regarding diabetes, hypertension, and cholesterol levels. In fact, the U.S. Preventive Services Task Force recommends that clinicians "screen all adults for obesity and offer or refer patients with a [body mass index] of 30 kg/m 2 or higher to intensive, multicomponent behavioral interventions." Because most clinicians do not offer multicomponent interventions in their offices, our review is designed to help them discuss commercial weight-loss options with their patients. Dr. Yancy and colleagues note that the term "behavioral counseling" might not completely describe the comparator interventions that included counseling on diet, exercise, or behavior modification of varying intensities. We acknowledge the heterogeneity of counseling comparators, which contributed to our decision not to present meta-analyses. We provided details about all comparator and intervention groups in Table 4 of the Supplement. Dr. Yancy and colleagues also expressed concern about the presentation of only comparative effectiveness results. Our stated purpose was to compare weight loss from commercial weight-loss programs versus that from control/education or counseling among overweight and obese adults. Thus, we emphasized comparative results to aid clinicians who often must weigh different treatment options for their patients. In fact, obesity counseling in clinical settings could become even more relevant, because it may be increasingly available to patients given recent benefit expansions within Medicare and through the Patient Protection and Affordable Care Act (3, 4 Another issue arises when this same question is evaluated in observational studies, where the concepts of "exposure" and "outcome" are explored. To my knowledge, the "exposure" actually consists of exposure to the drug prescription, not to the drug. It would be great if the investigators would include documentation of actual dosing in their publications. The intention-to-treat analysis is superb at controlling type I errors but does not intrinsically ensure that we know exactly which treatment the participants received.
Robert C. Kane, MD U.S. Food and Drug Administration Silver Spring, Maryland A recent meta-analysis (1) inadvertently omitted an eligible paper. The authors of the 2 papers in question were the same (Wijndaele was the first author for both). The authors of the meta-analysis believed that the papers had redundant outcomes (i.e., an update of outcomes from the same cohort). However, Wijndaele et al. (2011; Int J Epidemiol [2] ) examined all-cause mortality, CVD mortality, and cancer mortality, whereas PLoS ONE [3] ) examined CVD incidence. Also, the wrong Wijndaele citation was included in Figure 1 . The paper has been revised, and both papers are included in the meta-analysis. The results do not meaningfully change with the inclusion of the new study; the point estimates remain significant.
These corrections have been made to the online version.
